Liver-targeting iron oxide nanoparticles and their complexes with plant extracts for biocompatibility
2024

Liver-targeting iron oxide nanoparticles and their complexes with plant extracts for biocompatibility

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kazaryan Shushanik A, Oganian Seda A, Vardanyan Gayane S, Sidorenko Anatolie S, Hovhannisyan Ashkhen A

Primary Institution: Russian-Armenian (Slavonic) University

Hypothesis

This study evaluates the biocompatibility of iron oxide nanoparticles and their complexes with plant extracts on liver tissue.

Conclusion

Iron oxide nanoparticles and their complexes do not exhibit direct hepatotoxicity, but their combinations can affect liver function markers.

Supporting Evidence

  • Fe3O4 nanoparticles do not show direct hepatotoxicity when administered to rats.
  • All agents tested exert a hypolipidemic effect by lowering LDL cholesterol.
  • Fe3O4 nanoparticles increase the activity of glutathione peroxidase in liver tissue.

Takeaway

The study looks at tiny particles that can help deliver medicine to the liver without hurting it, but when mixed with certain plants, they can cause some problems.

Methodology

The study involved administering iron oxide nanoparticles and plant extracts to healthy Wistar rats and measuring various liver function markers.

Potential Biases

Potential bias may arise from the limited sample size and specific conditions under which the experiments were conducted.

Limitations

The study primarily focuses on a specific type of nanoparticles and their effects on liver function without exploring long-term impacts.

Participant Demographics

Healthy white Wistar rats were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3762/bjnano.15.125

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication